Apexigen to Recruit Children with Brain Tumors for Phase 1 Trial of Immunotherapy – Immuno-Oncology News
Immuno-Oncology News |
Apexigen to Recruit Children with Brain Tumors for Phase 1 Trial of Immunotherapy
Immuno-Oncology News Children with brain tumors that have failed to respond to treatment, or that have returned, will be able to enroll in a Phase 1 clinical trial evaluating an immunotherapy that Apexigen developed. The trial, a collaboration between Apexigen and the … |
